Patents by Inventor Patrick Leon

Patrick Leon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6590084
    Abstract: The present invention relates to a process for preparing 9-deoxo-9(Z)-hydroxyiminoerythromycin A corresponding to formula (I) below: from 9-deoxo-9(E)-hydroxyiminoerythromycin A by reaction with a base in water or in a mixture of water/solvent of dialkyl ketone type capable of forming a crystallizable solvate with the desired 9(Z)-oxime; acidification of the reaction mixture to a pH of between 9 and 11; addition to the said mixture of an organic solvent; optionally concentration under vacuum of the resulting organic phase; and isolation of the desired 9(Z)-erythromycin oxime.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: July 8, 2003
    Assignee: Merial
    Inventors: François Basset, Thierry Durand, Ronan Guevel, Patrick Leon, Frédéric Lhermitte, Gilles Oddon, Denis Pauze
  • Patent number: 6562953
    Abstract: The invention relates to a process for preparing compound of general formula I by reductive amination of the corresponding (4″)-carbonyl derivative, characterized in that it comprises: placing the said (4″)-carbonyl derivative in contact with at least one nitrogenous reagent and a Lewis acid under conditions that are favourable for converting the 4″ carbonyl function, reducing the resulting mixture using a reducing agent, and optionally deprotecting the hydroxyl function in position 2′, to give the expected compound of general formula I.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: May 13, 2003
    Assignee: Merial
    Inventors: Jildaz Dhainaut, Patrick Leon, Frédéric Lhermitte, Gilles Oddon
  • Patent number: 6482931
    Abstract: The invention provides a process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin A and of its 8a-alkylated derivatives from 9-deoxo-9(Z)-hydroxyiminoerythromycin A via a stereospecific Beckmann rearrangement in a reaction mixture using pyridine as main solvent, resulting in imidate intermediates which are not isolated from said mixture and which are employed directly in a reduction stage using a sufficient amount of borohydride, after extraction of the pyridine with a hydrocarbon which is miscible with the latter and in which said imidates are insoluble. The compound V can be directly N-alkylated at the 8a-position using an aldehyde without being isolated from the reduction mixture.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: November 19, 2002
    Assignee: Merial
    Inventors: Patrick Leon, Frederic Lhermitte, Gilles Oddon, Denis Pauze
  • Patent number: 6433172
    Abstract: This invention is directed to methods for stereospecifically preparing [(1-optionally substituted aryl)- or (1-optionally substituted heteroaryl)]-2-substituted ethyl-2-amines, having chirality at the 2-position, and to intermediates to the substituted ethyl-2-amines.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: August 13, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Luc Grondard, Jean-Paul Casimir, Patrick Leon, Michael K. O'Brien, Matthew R. Powers, Daniel Robin
  • Patent number: 6429315
    Abstract: This invention is directed to a process for preparing N6-substituted adenosine derivatives, to intermediates useful therefor and to methods of preparing these intermediates.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: August 6, 2002
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Adam W. Sledeski, Luc Grondard, Matthew R. Powers, Tory H. Powner, Michael K. O'Brien, Ching T. Tsuei, Patrick Leon, Gregory G. Kubiak, Laurence Pailleres-Hubert, Benoit Viguier
  • Publication number: 20020045756
    Abstract: The present invention relates to a novel process for preparation of camptothecin and of its derivatives by convergent synthesis starting from a 3-(aminomethyl)quinoline derivative and 5-hydroxy-5-ethyl-6-oxo-5,6-dihydropyrancarboxylic acid and to the intermediates obtained.
    Type: Application
    Filed: September 14, 2001
    Publication date: April 18, 2002
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Stefanie Leue, Stephanie Garcon, Andrew-Elliot Greene, Yves Genisson, Patrick Leon
  • Patent number: 6353096
    Abstract: The subject-matter of the invention is a process for the stereoselective preparation of a compound of general formula I by stereoselective displacement by a nitrogenous nucleophilic compound of the activated alcohol functional group present at this 4″ position in a corresponding derivative of formula II.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: March 5, 2002
    Assignee: Merial
    Inventors: Patrick Leon, Frederic Lhermitte, Ronan Guevel, Denis Pauze, Laurent Garel, Gilles Oddon
  • Publication number: 20020013454
    Abstract: The invention relates to a process for preparing compound of general formula I 1
    Type: Application
    Filed: May 16, 2001
    Publication date: January 31, 2002
    Inventors: Jildaz Dhainaut, Patrick Leon, Frederic Lhermitte, Gilles Oddon
  • Publication number: 20010047088
    Abstract: The invention provides a process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin A 1
    Type: Application
    Filed: March 22, 2001
    Publication date: November 29, 2001
    Inventors: Patrick Leon, Frederic Lhermitte, Gilles Oddon, Denis Pauze
  • Publication number: 20010034434
    Abstract: The present invention relates to a process for preparing 9-deoxo-9(Z)-hydroxyiminoerythromycin A corresponding to formula (I) below: 1
    Type: Application
    Filed: April 23, 2001
    Publication date: October 25, 2001
    Inventors: Francois Basset, Thierry Durand, Ronan Guevel, Patrick Leon, Frederic Lhermitte, Gilles Oddon, Denis Pauze
  • Patent number: 6235909
    Abstract: This invention is directed to methods for the preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[-(3-chloro-2-thienyl)methyl]propyl]amino]-3 H-imidazo[4,5-b]pyridin-3-yl]]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide, methods for the preparation of intermediates thereto, and to said intermediates themselves.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: May 22, 2001
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Herve Garcia, Patrick Leon, Benoit J. Vanasse
  • Patent number: 6180759
    Abstract: This invention is directed to a process for preparing a pseudotetrapeptide of formula I or a salt or prodrug thereof wherein is optionally nitrogen protected azaheterocyclyl; is a single or double bond; q is 1-5; B is alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, aralkyl, alkylaryl, or alkylaralkyl; Q2 is H or a carboxylic acid protecting group; J is —H, alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, substituted aryl, aralkyl, substituted aralkyl; L is OR1, or NR1R2, where R1 and R2 are independently —H, alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, aralkyl, alkylaryl or alkylaralkyl; and p is 1 or 2 which comprises the coupling of two dipeptides or psuedopeptides.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: January 30, 2001
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: James J. Mencel, Robert Stammler, Christophe Daubie, Michel Lavigne, Benoit J. Vanasse, Robert C. Liu, Patrick Leon, Geoffrey A. D'Netto, Adam W. Sledeski
  • Patent number: 6143894
    Abstract: This invention is directed to methods for the preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-chloro-2-thienyl) methyl]propyl]amino]-3H-imidazo[4,5-b]pyridin-3-yl]-N-ethyl-2,3-dihydroxyc yclopentanecarboxamide, methods for the preparation of intermediates thereto, and to said intermediates themselves.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: November 7, 2000
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Michael K. O'Brien, Herve Garcia, Patrick Leon, Tory H. Powner, Laurence W. Reilly, Harshavadan C. Shah, Michael D. Thompson, Ching T. Tsuei, Benoit J. Vanasse, Francis L. Walther
  • Patent number: 6127550
    Abstract: This invention is directed to methods for stereospecifically preparing [(1-optionally substituted aryl)- or (1-optionally substituted heteroaryl)]-2-substituted ethyl-2-amines, having chirality at the 2-position, and to intermediates to the substituted ethyl-2-amines.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: October 3, 2000
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: Luc Grondard, Jean-Paul Casimir, Patrick Leon, Michael K. O'Brien, Matthew R. Powers, Daniel Robin
  • Patent number: 5962705
    Abstract: The present invention relates to a novel process for preparing dialkoxy derivatives of the taxoid family by direct alkylation of the two positions 7 and 10 of deacetylbaccatin or derivatives thereof which are esterified in position 13.
    Type: Grant
    Filed: November 17, 1998
    Date of Patent: October 5, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Eric Didier, Gilles Oddon, Denis Pauze, Patrick Leon, Didier Riguet
  • Patent number: 5912365
    Abstract: Novel derivatives of 1R- or 1S-2-azabicyclo?2.2.1!heptane with the general formula (I) or (I'), preparation and their application. ##STR1## In the general formulas (I) and (I'), R represents a hydrogen atom or a group with the formula ##STR2## respectively, in which R.sub.1 represents an alkyl group containing 1-4 carbon atoms and Ar represents an optionally substituted phenyl or a- or b-naphthyl group.
    Type: Grant
    Filed: August 19, 1997
    Date of Patent: June 15, 1999
    Assignee: Rhone-Poulenc Rorer SA
    Inventors: Denis Largeau, Patrick Leon
  • Patent number: 5886192
    Abstract: A method for the preparation of a lactam compound of formula ##STR1## wherein R'.sub.1 and R".sub.1 independently are acyl or aroyl, or taken together form an optionally substituted methylene, and G.sub.1 is hydrogen or an amino protecting group, comprising oxidizing a bis O-protected 1R-2-azadihydroxybicyclo-?2.2.1!heptane compound of formula ##STR2## with about 0.1 mol % to about 1 mol % of RuO.sub.2 or hydrate thereof in the presence of about 3 equivalents of an oxidant to form the lactam compound with an enantiomeric excess of greater than or equal to about 95%.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: March 23, 1999
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Patrick Leon, Denis Largeau, Thierry Durand, Michael O'Brien, Matthew Powers
  • Patent number: 5831096
    Abstract: A method for the preparation of a compound of formula ##STR1## wherein R is hydrogen or, respectively, a group of formula ##STR2## R.sub.1 is alkyl; Ar is optionally substituted aryl; andR.sub.3' and R.sub.3" are hydrogen, alkyl or phenyl, or R.sub.3' and R.sub.3" taken together with the carbon atom to which they are attached form cycloalkyl, or salt thereof, comprising acid facilitated acetalizing or ketalizing of a compound of formula ##STR3## wherein R.sub.3' and R.sub.3" are as defined above, and R.sub.4' and R.sub.4" are alkoxy, or taken together with the carbon atom to which they are attached form carbonyl, with a compound of formula ##STR4## wherein * represents an R chirality;R, R.sub.1 and Ar are as defined above, or salt thereof in isopropanol.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: November 3, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Patrick Leon, Michael O'Brien, Denis Largeau, Matthew Powers, Ching Tsuei
  • Patent number: 5808093
    Abstract: A compound of formula ##STR1## wherein R is a group of formula ##STR2## R.sub.1 is alkyl; and Ar is optionally substituted aryl.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: September 15, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Michael O'Brien, Patrick Leon, Denis Largeau, Ching Tsuei, Thierry Durand
  • Patent number: RE40040
    Abstract: The subject-matter of the invention is a process for the stereoselective preparation of a compound of general formula I by stereoselective displacement by a nitrogenous nucleophilic compound of the activated alcohol functional group present at this 4? position in a corresponding derivative of formula II.
    Type: Grant
    Filed: September 9, 2005
    Date of Patent: January 29, 2008
    Assignee: Merial Limited
    Inventors: Patrick Leon, Frederic Lhermitte, Ronan Guevel, Denis Pauze, Laurent Garel, Gilles Oddon